Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neutec İlaç is a prominent Turkish pharmaceutical company that focuses on the manufacturing and marketing of generic pharmaceutical products across a wide range of therapeutic areas. Headquartered in Istanbul with significant manufacturing operations in Sakarya, the company is a key player in the Turkish healthcare sector and has a growing international presence. Neutec is particularly noted for its expertise in respiratory medicine, offering a variety of inhalation therapies including dry powder and metered-dose inhalers. Their portfolio also includes significant offerings in cardiovascular, central nervous system, and anti-infective treatments. The company invests heavily in R&D through its dedicated research arm to ensure high-quality, accessible medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NEUTEC İlaç.